Literature DB >> 12087140

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.

Ronnier J Aviles1, Arman T Askari, Bertil Lindahl, Lars Wallentin, Gang Jia, E Magnus Ohman, Kenneth W Mahaffey, L Kristin Newby, Robert M Califf, Maarten L Simoons, Eric J Topol, Peter Berger, Michael S Lauer.   

Abstract

BACKGROUND: Among patients with suspected acute coronary syndromes, cardiac troponin T levels have prognostic value. However, there is concern that renal dysfunction may impair the prognostic value, because cardiac troponin T may be cleared by the kidney.
METHODS: We analyzed the outcomes in 7033 patients enrolled in the Global Use of Strategies to Open Occluded Coronary Arteries IV trial who had complete base-line data on troponin T levels and creatinine clearance rates. The troponin T level was considered abnormal if it was 0.1 ng per milliliter or higher, and creatinine clearance was assessed in quartiles. The primary end point was a composite of death or myocardial infarction within 30 days.
RESULTS: Death or myocardial infarction occurred in 581 patients. Among patients with a creatinine clearance above the 25th percentile value of 58.4 ml per minute, an abnormally elevated troponin T level was predictive of an increased risk of myocardial infarction or death (7 percent vs. 5 percent; adjusted odds ratio, 1.7; 95 percent confidence interval, 1.3 to 2.2; P<0.001). Among patients with a creatinine clearance in the lowest quartile, an elevated troponin T level was similarly predictive of increased risk (20 percent vs. 9 percent; adjusted odds ratio, 2.5; 95 percent confidence interval, 1.8 to 3.3; P<0.001). When the creatinine clearance rate was considered as a continuous variable and age, sex, ST-segment depression, heart failure, previous revascularization, diabetes mellitus, and other confounders had been accounted for, elevation of the troponin T level was independently predictive of risk across the entire spectrum of renal function.
CONCLUSIONS: Cardiac troponin T levels predict short-term prognosis in patients with acute coronary syndromes regardless of their level of creatinine clearance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12087140     DOI: 10.1056/NEJMoa013456

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  58 in total

1.  Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study.

Authors:  Sunil K Agarwal; Christy L Avery; Christie M Ballantyne; Diane Catellier; Vijay Nambi; Justin Saunders; A Richey Sharrett; Josef Coresh; Gerardo Heiss; Ron C Hoogeveen
Journal:  Clin Chem       Date:  2011-04-25       Impact factor: 8.327

Review 2.  Clinical implications of the new definition of myocardial infarction.

Authors:  John K French; Harvey D White
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

3.  A review of troponins in ischemic heart disease and other conditions.

Authors:  Nedaa Skeik; Deevia Chandrakant Patel
Journal:  Int J Angiol       Date:  2007

4.  Sex, Myocardial Infarction, and the Failure of Risk Scores in Women.

Authors:  Shilpa Agrawal; Jennifer Van Eyk; Kimia Sobhani; Janet Wei; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2015-08-19       Impact factor: 2.681

5.  Sequential cardiac troponin T following delivery and its relationship with myocardial performance in neonates with respiratory distress syndrome.

Authors:  Simon J Clark; Paul Newland; C William Yoxall; Nimish V Subhedar
Journal:  Eur J Pediatr       Date:  2005-10-15       Impact factor: 3.183

Review 6.  Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes.

Authors:  Ankie Amos; L Kristin Newby
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

Review 7.  Differential diagnosis of elevated troponins.

Authors:  Susanne Korff; Hugo A Katus; Evangelos Giannitsis
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

Review 8.  Perspective on the clinical application of troponin in heart failure and states of cardiac injury.

Authors:  Almasa Bass; J Herbert Patterson; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2009-04-05       Impact factor: 4.214

9.  Prognostic value of SPECT myocardial perfusion imaging in patients with elevated cardiac troponin I levels and atypical clinical presentation.

Authors:  Sharmila Dorbala; Robert P Giugliano; Giridhar Logsetty; Divya Vangala; Rakesh Mishra; Sharon Crugnale; David Yang; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

10.  Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure.

Authors:  Varvara Askiti; Kristine Hendrickson; Alfred J Fish; Elizabeth Braunlin; Alan R Sinaiko
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.